Rutherford Health Plc
The three centres, based in Newport, South Wales, Bomarsund, Northumberland and at Reading, are the first to offer high energy proton beam therapy in the United Kingdom with the first patients having received PBT at the Group's oncology centre in Newport in April 2018.
| Symbol | Ccy Code | Bid | Ask | Share Price (Mid) | Previous Close | Volume | Last Traded |
|---|---|---|---|---|---|---|---|
| RUTH | GBX | 180 | 190 | 185 | 185 | 267 | 14.01.22 |
MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.
Address
Business Address
Rutherford Health plc, Suite 4 Penn House, 9-10 Broad Street, Hereford, HR4 9AP, United Kingdom.
Registered Address
15 Bridge Street, Hereford, HR4 9DF, United Kingdom.
Contacts
Corporate Adviser
Grant Thornton UK LLP., 30 Finsbury Square, London, United Kingdom.
Email: website.enquiries.general@uk.gt.com
Phone: 020 7383 5100
Registrar
Share Registrars Ltd, The Courtyard, 17 West Street, Farnham, Surrey, GU9 7DR, United Kingdom.
Email: enquiries@shareregistrars.uk.com
Phone: 01252 821390
Research
I'm sorry there is no research for this company.